Company

PharmaEngine, Inc.

Headquarters: Taipei, Taiwan

CEO: Mr. Hong-Ren Wang Ph.D.

TWSE: 4162 -4.23%

Market Cap

TW$13.38 Billion

TWD as of July 1, 2024

US$411.0 Million

Market Cap History

PharmaEngine, Inc. market capitalization over time

Evolution of PharmaEngine, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of PharmaEngine, Inc.

Detailed Description

PharmaEngine, Inc., a biopharmaceutical company, engages in the development and licensing of drugs and therapeutic drugs for treating cancer diseases in Taiwan and Europe. It is developing ONIVYDE for patients with gemcitabine-treated metastatic pancreatic cancer;PEP06, which is in Phase I stage for the treatment of cancer; and PEP07, an oral small molecule drug, which is in preclinical development stage to regulate DNA damage response. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

PharmaEngine, Inc. has the following listings and related stock indices.


Stock: TWSE: 4162 wb_incandescent

Details

Headquarters:

10 Minsheng East Road

11th Floor Sec. 3

Taipei, 104

Taiwan

Phone: 886 2 2515 8228

Fax: 886 2 2515 7558